Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas

Immune checkpoint inhibitors have revolutionized cancer treatment in the last decade. Despite the progress in immunotherapy, most pancreatic cancer patients still do not derive benefit when receiving immune-based therapies. Recently, resistance mechanisms to immune therapies have been mainly focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokas, Alexandros, Papakotoulas, Pavlos, Sarantis, Panagiotis, Papadimitropoulou, Adriana, Papavassiliou, Athanasios G, Karamouzis, Michalis V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072375/
https://www.ncbi.nlm.nih.gov/pubmed/32069809
http://dx.doi.org/10.3390/cancers12020432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072375/
https://www.ncbi.nlm.nih.gov/pubmed/32069809
http://dx.doi.org/10.3390/cancers12020432

Ejemplares similares